Search Results

Pharm Country

Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)

Neurotech Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA), has determined that the Biologic License Application (BLA) for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review.

June 20, 2024

·

3 min read

Biotech Beach

Convergent Research Announces Major New Funding Commitment to Forest Neurotech

Convergent Research today announced a new $14 million funding commitment from former Google CEO Eric Schmidt to Forest Neurotech, an initiative designed to create next-generation brain-computer-interfaces (BCIs) for individuals with neurological injuries or diseases.

March 11, 2024

·

2 min read

Business

Alex Gorsky Joins Neurotech’s Board as Lead Director

Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director.

September 13, 2023

·

3 min read

Lone Star Bio

Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression

Motif Neurotech announced today an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures.

January 24, 2024

·

3 min read

Business

Motif Neurotech Strengthens Leadership Team with Appointment of Steven Goetz as Chief Technology Officer

Motif Neurotech , a clinical-stage company developing minimally invasive bioelectronics for mental health, announces the appointment of Steven Goetz as Chief Technology Officer.

July 24, 2023

·

4 min read

Lone Star Bio

Motif Neurotech Conducts First-in-human Brain Stimulation With Millimeter-sized Implantable Device for Treatment-resistant Depression

Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health, announced today new research published to the preprint server medrxiv that demonstrates a millimeter-sized brain stimulator in a human subject.

September 18, 2023

·

5 min read

Biotech Beach

Neurotech Solutions Debuts MOXOedu Attention Assessment at ASU+GSV Summit

Neurotech Solutions continues to revolutionize attentional analytics with MOXOedu, a cloud-based tool that has been calibrated for assessing and profiling human attention

April 18, 2023

·

3 min read

Biotech Bay

New Pilot Study Using the FDA-Cleared Cionic Neural Sleeve Demonstrates Significant Improvements to Gait Impairments for Patients with Multiple Sclerosis

CIONIC, the neurotech inventor pioneering bionic clothing, today announced data showcasing the impact of the FDA-cleared Cionic Neural Sleeve as assistive technology for individuals experiencing difficulty walking due to multiple sclerosis (MS).

May 28, 2024

·

3 min read

Pharm Country

Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier

Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced the first third-party reimbursement from a major insurance carrier for the Company’s Portable Neuromodulation Stimulator device.

May 29, 2024

·

5 min read

Business

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended March 31, 2024.

May 13, 2024

·

10 min read